Literature DB >> 2741736

Hydatid disease affecting the vertebrae.

M Kaoutzanis1, D Anagnostopoulos, A Apostolou.   

Abstract

Six cases of hydatid disease affecting the vertebrae are described. Four patients presented with paraparesis and sphincter disturbances while the other two presented with low back pain and sciatica. Myelographic findings were positive in all six patients. The CT scans showed a paravertebral mass with destruction of bone in two cases. The nuclear magnetic resonance performed in one patient showed the exact extent of the disease all along the spine. Posterior laminectomy with decompression of the spinal cord and removal of the hydatid cysts was performed in all six patients. After the operation four patients received oral treatment with mebendazole. The patients with paraparesis showed little improvement of their neurological status. The two patients with low back pain and sciatica showed marked improvement. Hydatid disease affecting the vertebrae presents with neurological complications due to cord compression. The prognosis remains poor in spite of laminectomy, although removal of the hydatid cysts and long-term mebendazole medication may result in relief of symptoms.

Entities:  

Mesh:

Year:  1989        PMID: 2741736     DOI: 10.1007/bf01407178

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  20 in total

1.  Observations on the current and future surgical management of hydatid disease affecting the vertebrae.

Authors:  B Levack; J Kernohan; M A Edgar; A O Ransford
Journal:  Spine (Phila Pa 1976)       Date:  1986 Jul-Aug       Impact factor: 3.468

2.  Anthelmintic activity of mebendazole against Cysticercus fasciolaris.

Authors:  D Thienpont; O Vanparijs; L Hermans
Journal:  J Parasitol       Date:  1974-12       Impact factor: 1.276

3.  Vertebral hydatidosis.

Authors:  G R Stewart; J Loewenthal
Journal:  Aust N Z J Surg       Date:  1967-02

4.  [Spinal echinococcosis; clinical study of 32 cases (author's transl)].

Authors:  A Bettaieb; M Khaldi; T Ben Rhouma; S Touibi
Journal:  Neurochirurgie       Date:  1978       Impact factor: 1.553

5.  Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases.

Authors:  A Bekhti; M Nizet; M Capron; J P Dessaint; F Santoro; A Capron
Journal:  Acta Gastroenterol Belg       Date:  1980 Jan-Feb       Impact factor: 1.316

6.  Effect of parenterally injected benzimidazole compounds on Echinococcus multilocularis and Taenia crassiceps metacestodes in laboratory animals.

Authors:  W C Campbell; R O McCracken; L S Blair
Journal:  J Parasitol       Date:  1975-10       Impact factor: 1.276

7.  Mebendazole.

Authors:  J S Keystone; J K Murdoch
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

8.  Albendazole in the treatment of cystic hydatid disease.

Authors:  R Esposito; G Orlando; P Crocchiolo; A Lazzarin; A D'Arminio Monforte; M Moroni
Journal:  Boll Ist Sieroter Milan       Date:  1986

9.  Hydatid disease of the spine causing paraplegia. The combined treatment by surgical drainage and mebendazole: a case report.

Authors:  S Porat; G C Robin; G Wertheim
Journal:  Spine (Phila Pa 1976)       Date:  1984-09       Impact factor: 3.468

10.  [Spinal hydatidosis treated by albendazole. A propos of 2 cases].

Authors:  J P Fournier; P Marty; E Bernard; P Leloire; P Dellamonica; Y Le Fichoux
Journal:  Pathol Biol (Paris)       Date:  1985-06
View more
  3 in total

Review 1.  Infections of the spine.

Authors:  J L Antunes
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Hydatid disease of the spine: a survey study from Turkey.

Authors:  M Turgut
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

3.  Isolated primary spinal epidural hydatid cyst in a child with progressive paraparesis.

Authors:  Samuel Berchi Kankam; Ghazaleh Kheiri; Moeinadin Safavi; Zohreh Habibi; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2021-03-08       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.